I repeat:
1. GCDx changed their "Order" page.
2. They still do not mention Radient anywhere on the website.
3. It looks like they are going to charge $99 for DR70.
That's what I said and nothing more, but I'll repeat it in a numbered list if that aids comprehension.
Of course GCDx is not going to call their test "DR70" or "onko-sure." Radient failed abysmally with the DR70 and onko-sure names -- even if Gartner *could* call it DR70 or onko-sure, he most certainly would not. He's putting lipstick on the pig and calling it "the Lung Cancer Test for Early Detection."
I hope nobody is refuting the idea that Gartner's test is DR70 and nothing more. Gartner used the test data for DR-70 in his PR and Fundable descriptions.
Oh, I also said "I wonder what the FDA will think of GCDx trying to sell DR70 now." the link I provided has the sentence:
" CLICK HERE to order one right through our store,"
And the link leads to a checkout page. Yes, the preceding sentence says "This site is for testing only at this time." But that is very amateurish -- the FDA will probably look at that with suspicion. A professional company would NEVER put a test page online where the public can see it. The only excuse GCDx can offer the FDA is "we are rookies and poorly funded, we don't know any better."
IMO, everything about the GCDx website screams "mom and pop." There are no deep pockets behind GCDx -- if they had funding they wouldn't be embarrassing themselves on Fundable, they'd hire a real web app developer, they would NOT be using PayPal to charge credit cards, and they would NOT put test pages online in that manner.
There is no Radient takeover behind GCDX, in other words. Gartner is doing this on his own.
AI
